Inventor · disambiguated record
David Polidori
Also filed as: POLIDORI DAVID · POLIDORI DAVID C · POLIDORI DAVID CHARLES
4 granted patents·9 pending applications·29 citations·filing 2004–2024
70Inventor score
Top patents by PatentIndex Score
13 records- 0185US11939361B2Compositions of peptide inhibitors of Interleukin-23 receptorJANSSEN PHARMACEUTICA NV·Filed 2021·Granted Mar 26, 2024·2 cites·16 claims
- 0278US11207337B2Co-therapy comprising canagliflozin and phentermine for the treatment of obesity and obesity related disordersJANSSEN PHARMACEUTICA NV·Filed 2020·Granted Dec 28, 2021·1 cites·10 claims
- 0376US7654955B2Apparatus and methods for assessing metabolic substrate utilizationENTELOS INC·Filed 2004·Granted Feb 2, 2010·26 cites·16 claims
- 0464US2024254180A1Compositions of peptide inhibitors of interleukin-23 receptorJANSSEN PHARMACEUTICA NV·Filed 2024·Application pending·0 cites
- 0560US12390451B2Small molecule inhibitor of the JAK family of kinasesJANSSEN PHARMACEUTICA NV·Filed 2022·Granted Aug 19, 2025·0 cites·12 claims
- 0652US2019142855A1Co-therapy comprising canagliflozin and phentermine for the treatment of obesity and obesity related disordersJANSSEN PHARMACEUTICA NV·Filed 2019·Application pending·0 cites
- 0750US2008120039A1Hormone and drug concentrations in the portal vein and hepatic sinusoidsENTELOS INC·Filed 2006·Application pending·0 cites
- 0847US2007071681A1Apparatus and method for computer modeling type 1 diabetesENTELOS INC·Filed 2006·Application pending·0 cites
- 0945US2007026365A1Defining virtual patient populationsENTELOS INC·Filed 2006·Application pending·0 cites
- 1045US2007032420A1Treating diabetes with glucagon-like peptide-1 secretagoguesENTELOS INC·Filed 2006·Application pending·0 cites
- 1145US2017071970A1Co-therapy comprising canagliflozin and phentermine for the treatment of obesity and obesity related disordersJANSSEN PHARMACEUTICA NV·Filed 2016·Application pending·0 cites
- 1242US2008262745A1Method for Determining Insulin Sensitivity and Glucose AbsorptionPOLIDORI DAVID CHARLES·Filed 2008·Application pending·0 cites
- 1340US2007026458A1Assessing insulin resistance using biomarkersENTELOS INC·Filed 2005·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →